Detalhe da pesquisa
1.
Outcomes of HLA-mismatched HSCT with TCRαß/CD19 depletion or post-HSCT cyclophosphamide for inborn errors of immunity.
Blood;
2024 Apr 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38669631
2.
A new step in understanding stem cell mobilization in patients with Fanconi anemia: A bridge to gene therapy.
Transfusion;
62(1): 165-172, 2022 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34751952
3.
Gene Therapy in Patients with Transfusion-Dependent ß-Thalassemia.
N Engl J Med;
378(16): 1479-1493, 2018 04 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29669226
4.
Vascular access for optimal hematopoietic stem cell collection.
J Clin Apher;
36(1): 12-19, 2021 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32854142
5.
Therapeutic plasma exchange for life-threatening pediatric disorders.
J Clin Apher;
36(6): 823-830, 2021 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34469617
6.
Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Primary Immunodeficiencies and Inherited Disorders in Children.
Biol Blood Marrow Transplant;
25(7): 1363-1373, 2019 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30876929
7.
Mammalian target of rapamycin inhibition counterbalances the inflammatory status of immune cells in patients with chronic granulomatous disease.
J Allergy Clin Immunol;
139(5): 1641-1649.e6, 2017 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27702670
8.
Cutaneous and Visceral Chronic Granulomatous Disease Triggered by a Rubella Virus Vaccine Strain in Children With Primary Immunodeficiencies.
Clin Infect Dis;
64(1): 83-86, 2017 Jan 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27810866
9.
Improving the diagnostic efficiency of primary immunodeficiencies with targeted next-generation sequencing.
J Allergy Clin Immunol;
147(2): 734-737, 2021 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32531373
10.
Long-term outcomes of lentiviral gene therapy for the ß-hemoglobinopathies: the HGB-205 trial.
Nat Med;
28(1): 81-88, 2022 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35075288
11.
Bayesian Modeling Immune Reconstitution Apply to CD34+ Selected Stem Cell Transplantation for Severe Combined Immunodeficiency.
Front Pediatr;
9: 804912, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35242727
12.
Ex vivo generated human T-lymphoid progenitors as a tool to accelerate immune reconstitution after partially HLA compatible hematopoietic stem cell transplantation or after gene therapy.
Bone Marrow Transplant;
54(Suppl 2): 749-755, 2019 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31431705
13.
Chronic Intestinal Pseudo-Obstruction and Lymphoproliferative Syndrome as a Novel Phenotype Associated With Tetratricopeptide Repeat Domain 7A Deficiency.
Front Immunol;
10: 2592, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31787977
14.
Author Correction: Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome.
Nat Genet;
51(1): 196, 2019 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30429576
15.
Performance of the QuantiFERON-TB Gold Assay Among HIV-infected Children With Active Tuberculosis in France.
Pediatr Infect Dis J;
37(4): 339-344, 2018 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28877156
16.
Ontogeny of human mucosal-associated invariant T cells and related T cell subsets.
J Exp Med;
215(2): 459-479, 2018 02 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29339446
17.
Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome.
Nat Genet;
50(12): 1650-1657, 2018 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30374066
18.
Correction to: Ex vivo generated human T-lymphoid progenitors as a tool to accelerate immune reconstitution after partially HLA compatible hematopoietic stem cell transplantation or after gene therapy.
Bone Marrow Transplant;
57(5): 851, 2022 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35297407
19.
Efficiency of continuous venous-venous hemodiafiltration in a life-threatening phenytoin poisoning: A case report.
Therapie;
76(6): 751-754, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33743990
20.
[DICER1: A new model of epigenetic tumor suppressor gene]. / DICER1 : un nouveau modèle épigénétique de gène suppresseur de tumeurs.
Bull Cancer;
102(10): 802-3, 2015 Oct.
Artigo
em Francês
| MEDLINE
| ID: mdl-26387821